Generic placeholder image

Current Pharmaceutical Biotechnology


ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

ADAMTS Proteinases: Potential Therapeutic Targets?

Author(s): Gavin C. Jones

Volume 7, Issue 1, 2006

Page: [25 - 31] Pages: 7

DOI: 10.2174/138920106775789656

Price: $65


ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) proteinases have been implicated in a number of connective tissue pathologies including Ehlers-Danlos syndrome type VII C, Weill-Marchesani syndrome, encephalomyelitis, and arthritis. These proteinases therefore represent potential therapeutic targets for the treatment of such conditions. The synthesis and activity of ADAMTS proteinases is regulated at multiple levels: transcription, RNA splicing, translation, proteolytic processing, cofactor stimulation and inhibition, each of which represents a possible point of therapeutic intervention. Recent research suggests that, in addition to the direct inhibition of ADAMTS proteinases with low molecular weight non-peptidic inhibitors, targeting the transcription and protein processing of these enzymes could be effective therapeutic approaches.

Keywords: ADAMTS, metalloproteinase, regulation, therapy

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy